# Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism

> **NCT01360996** · PHASE4 · COMPLETED · sponsor: **Woman's** · enrollment: 64 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** 3 mg DRSP/20 μg EE

## Key facts

- **NCT ID:** NCT01360996
- **Lead sponsor:** Woman's
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2017-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01360996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01360996, "Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01360996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*